MON2 and coronary artery disorder: As a result, we have observed that not only a higher Mon2 subset circulating fraction but also a higher expression level of its activation markers (CD16), adhesion molecules (CD18), and chemokine receptors (CX3CR1) are independently correlated with more advanced CAD stage.